Currently serving as Director of the Drug Metabolism and Pharmacokinetics Department at Novartis Institute for Biomedical Research, Imad is responsible for leading investigations aimed at determining the enzymes and transporters responsible for elimination from the body and trafficking across various cellular barriers. Imad Hanna is an expert in the pharmaceutical industry, with over 15 years of experience in the industry specializing in the field of drug metabolism and transport.
Working in the field of drug metabolism has been a natural fit for Dr. Hanna, as it combines two of his favorite disciplines: biology and chemistry. His path towards a career in the pharmaceutical industry began at Oakland University, where he earned a Bachelor of Science Degree from the Department of Chemistry. He later went on to attend Wayne State University, earning a Ph.D., from the Department of Pharmacology.
Outside of his professional endeavors in the laboratory, Imad Hanna is committed to advancing the field through his work in the classroom. He currently serves as an Adjunct Associate Professor at Rutger University’s Ernest Mario School of Pharmacy. He has also played an instrumental role in over 25 different publications and two books related to drug metabolism.
In recognition of his expertise in the field of drug metabolism, Imad Hanna has frequently been asked to serve as a speaker and lecturer at a number of industry events. Additionally, he spent time as a Chairperson with the North Jersey Chapter of the American Chemical Society.
Imad Hanna 